FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression
PR Newswire - FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression Treatment The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder. Arch Gen Psychiatry. 2002; 59
Source: sev.prnewswire.com
Click here for more information about information on depression 2 information on depression 2
<< Home